The effect of inhaled fluticason propionate on intraocular pressure of patients with bronchial asthma

D. Vidanovic, G. Vidanovic (Sokobanja, Serbia And Montenegro)

Source: Annual Congress 2006 - Asthma - miscellaneous issues
Session: Asthma - miscellaneous issues
Session type: Electronic Poster Session
Number: 2886
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Vidanovic, G. Vidanovic (Sokobanja, Serbia And Montenegro). The effect of inhaled fluticason propionate on intraocular pressure of patients with bronchial asthma. Eur Respir J 2006; 28: Suppl. 50, 2886

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days
Source: Eur Respir J 2002; 20: Suppl. 38, 197s
Year: 2002

The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

Effect of the addition of montelukast to inhaled fluticasone propionate on immunopathology in bronchial biopsies from mild to moderate asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 388s
Year: 2002

Response to fluticasone propionate in controlling airway inflammation in steroid-naïve asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 317s
Year: 2006

Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002

Effect of discontinuation of inhaled fluticasone propionate on exacerbations in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 183s
Year: 2001

The effects of fluticasone propionate in asthmatic patients
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Airway and systemic effects of hydrofluoroalkane formulations of high dose ciclesonide and fluticasone propionate in moderate persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 583s
Year: 2004

Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Effect of addition of salmeterol vs doubling the dose of fluticasone propionate on specific airway resistance in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
Source: Eur Respir J 2004; 23: 559-564
Year: 2004



Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma
Source: Eur Respir J 2009; 33: 1277-1286
Year: 2009



Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Airway hyperresponsiveness and treatment effectiveness during a one year study of the combination of salmeterol and fluticasone propionate (FP) compared with FP and salmeterol alone in mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Source: Eur Respir J 2004; 23: 354-355
Year: 2004


Inhalation of fluticasone propionate spray compared with theophilline as primary treatment for chronic mild to moderate asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006